[Xanthogranuloma and cutaneous mastocytosis in adults].

N Benzerara(Hôpital d'instruction des Armées Desgenettes), B Chouvet, Jean Kanitakis(Hôpital Lyon Sud), R Abitan, B. Guennoc(Hôpital d'instruction des Armées Desgenettes), P. Combemale(Centre Léon Bérard)

PubMed

January 1, 1994

Cited by 2

Related Papers

Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial

|The Lancet Oncology|2015|432

Long‐term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42‐month analysis of the phase II randomized, double‐blind BOLT study

|British Journal of Dermatology|2019|197

Translocation, t(17;22)(q22;q13), in dermatofibrosarcoma protuberans: a new tumor-associated chromosome rearrangement

|Cytogenetics and Cell Genetics|2008|194

Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study

|Journal of the European Academy of Dermatology and Venereology|2017|192

Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966

|Orphanet Journal of Rare Diseases|2020|188